Atlas Trials

IMPACT: A Study to Explore the Efficacy and Safety of Paliperidone ER in Patients With Acute Agitation

Clinical trial NCT01050478 · COMPLETED

Trial details

NCT number
NCT01050478
Sponsor
Janssen Cilag N.V./S.A.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Psychomotor AgitationAcute Disease
Start date
2010-03-01
Primary completion
2011-12-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.